AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
SEROTONIN SYNDROME AFTER CHALLENGE WITH THE 5-HT AGONIST META-CHLOROPHENYLPIPERAZINE
Authors: KLAASSEN T PIAN KLH WESTENBERG HGM DENBOER JA VANPRAAG HM
Citation: T. Klaassen et al., SEROTONIN SYNDROME AFTER CHALLENGE WITH THE 5-HT AGONIST META-CHLOROPHENYLPIPERAZINE, Psychiatry research, 79(3), 1998, pp. 207-212
THE NATURE OF SOCIAL ANXIETY DISORDER
Authors: WESTENBERG HGM
Citation: Hgm. Westenberg, THE NATURE OF SOCIAL ANXIETY DISORDER, The Journal of clinical psychiatry, 59, 1998, pp. 20-26
CONSENSUS STATEMENT ON SOCIAL ANXIETY DISORDER FROM THE INTERNATIONALCONSENSUS GROUP ON DEPRESSION AND ANXIETY
Authors: BALLENGER JC DAVIDSON JRT LECRUBIER Y NUTT DJ BOBES J BEIDEL DC ONO Y WESTENBERG HGM
Citation: Jc. Ballenger et al., CONSENSUS STATEMENT ON SOCIAL ANXIETY DISORDER FROM THE INTERNATIONALCONSENSUS GROUP ON DEPRESSION AND ANXIETY, The Journal of clinical psychiatry, 59, 1998, pp. 54-60
TREATMENT OF ANXIETY AND PANIC
Authors: WESTENBERG HGM
Citation: Hgm. Westenberg, TREATMENT OF ANXIETY AND PANIC, British Journal of Pharmacology, 123, 1998, pp. 354-354
EFFECTS OF META-CHLOROPHENYLPIPERAZINE ON CEREBRAL BLOOD-FLOW IN OBSESSIVE-COMPULSIVE DISORDER AND CONTROLS
Authors: PIAN KLH WESTENBERG HGM DENBOER JA DEBRUIN WI VANRIJK PP
Citation: Klh. Pian et al., EFFECTS OF META-CHLOROPHENYLPIPERAZINE ON CEREBRAL BLOOD-FLOW IN OBSESSIVE-COMPULSIVE DISORDER AND CONTROLS, Biological psychiatry, 44(5), 1998, pp. 367-370
EFFECT OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR FLUVOXAMINE ON CCK-4 INDUCED PANIC ATTACKS
Authors: VANMEGEN HJGM WESTENBERG HGM DENBOER JA SLAAP B SCHEEPMAKERS A
Citation: Hjgm. Vanmegen et al., EFFECT OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR FLUVOXAMINE ON CCK-4 INDUCED PANIC ATTACKS, Psychopharmacology, 129(4), 1997, pp. 357-364
THE CHOLECYSTOKININ-B RECEPTOR ANTAGONIST CI-988 FAILED TO AFFECT CCK-4 INDUCED SYMPTOMS IN PANIC DISORDER PATIENTS
Authors: VANMEGEN HJGM WESTENBERG HGM DENBOER JA SLAAP B VANESRADHAKISHUN F PANDE AC
Citation: Hjgm. Vanmegen et al., THE CHOLECYSTOKININ-B RECEPTOR ANTAGONIST CI-988 FAILED TO AFFECT CCK-4 INDUCED SYMPTOMS IN PANIC DISORDER PATIENTS, Psychopharmacology, 129(3), 1997, pp. 243-248
CLINICAL EFFECTS OF BUSPIRONE IN SOCIAL PHOBIA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
Authors: VANVLIET IM DENBOER JA WESTENBERG HGM PIAN KLH
Citation: Im. Vanvliet et al., CLINICAL EFFECTS OF BUSPIRONE IN SOCIAL PHOBIA - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, The Journal of clinical psychiatry, 58(4), 1997, pp. 164-168
POSTSYNAPTIC 5-HT1A RECEPTORS MEDIATE 5-HYDROXYTRYPTAMINE RELEASE IN THE AMYGDALA THROUGH A FEEDBACK TO THE CAUDAL LINEAR RAPHE
Authors: BOSKER FJ KLOMPMAKERS A WESTENBERG HGM
Citation: Fj. Bosker et al., POSTSYNAPTIC 5-HT1A RECEPTORS MEDIATE 5-HYDROXYTRYPTAMINE RELEASE IN THE AMYGDALA THROUGH A FEEDBACK TO THE CAUDAL LINEAR RAPHE, European journal of pharmacology, 333(2-3), 1997, pp. 147-157
ANXIOGENIC EFFECTS OF PENTAGASTRIN IN PATIENTS WITH SOCIAL PHOBIA ANDHEALTHY CONTROLS
Authors: VANVLIET IM WESTENBERG HGM SLAAP BR DENBOER JA PIAN KLH
Citation: Im. Vanvliet et al., ANXIOGENIC EFFECTS OF PENTAGASTRIN IN PATIENTS WITH SOCIAL PHOBIA ANDHEALTHY CONTROLS, Biological psychiatry, 42(1), 1997, pp. 76-78
MHPG AND HEART-RATE AS CORRELATES OF NONRESPONSE TO DRUG-THERAPY IN PANIC DISORDER PATIENTS - A PRELIMINARY-REPORT
Authors: SLAAP BR VANVLIET IM WESTENBERG HGM DENBOER JA
Citation: Br. Slaap et al., MHPG AND HEART-RATE AS CORRELATES OF NONRESPONSE TO DRUG-THERAPY IN PANIC DISORDER PATIENTS - A PRELIMINARY-REPORT, Psychopharmacology, 127(4), 1996, pp. 353-358
EFFECTS OF THE 5-HT1A RECEPTOR AGONIST FLESINOXAN IN PANIC DISORDER
Authors: VANVLIET IM WESTENBERG HGM DENBOER JA
Citation: Im. Vanvliet et al., EFFECTS OF THE 5-HT1A RECEPTOR AGONIST FLESINOXAN IN PANIC DISORDER, Psychopharmacology, 127(2), 1996, pp. 174-180
PENTAGASTRIN HAS PANIC INDUCING PROPERTIES IN OBSESSIVE-COMPULSIVE DISORDER
Authors: DELEEUW AS DENBOER JA SLAAP BR WESTENBERG HGM
Citation: As. Deleeuw et al., PENTAGASTRIN HAS PANIC INDUCING PROPERTIES IN OBSESSIVE-COMPULSIVE DISORDER, Psychopharmacology, 126(4), 1996, pp. 339-344
CHOLECYSTOKININ IN ANXIETY
Authors: VANMEGEN HJGM WESTENBERG HGM DENBOER JA KAHN RS
Citation: Hjgm. Vanmegen et al., CHOLECYSTOKININ IN ANXIETY, European neuropsychopharmacology, 6(4), 1996, pp. 263-280
THE PANIC-INDUCING PROPERTIES OF THE CHOLECYSTOKININ TETRAPEPTIDE CCK4 IN PATIENTS WITH PANIC DISORDER
Authors: VANMEGEN HJGM WESTENBERG HGM DENBOER JA KAHN RS
Citation: Hjgm. Vanmegen et al., THE PANIC-INDUCING PROPERTIES OF THE CHOLECYSTOKININ TETRAPEPTIDE CCK4 IN PATIENTS WITH PANIC DISORDER, European neuropsychopharmacology, 6(3), 1996, pp. 187-194
BEHAVIORAL, NEUROENDOCRINE AND BIOCHEMICAL EFFECTS OF DIFFERENT DOSESOF 5-HTP IN PANIC DISORDER
Authors: VANVLIET IM SLAAP BR WESTENBERG HGM DENBOER JA
Citation: Im. Vanvliet et al., BEHAVIORAL, NEUROENDOCRINE AND BIOCHEMICAL EFFECTS OF DIFFERENT DOSESOF 5-HTP IN PANIC DISORDER, European neuropsychopharmacology, 6(2), 1996, pp. 103-110
TOLERANCE AND EFFICACY OF D-CYCLOSERINE IN DRUG-FREE SCHIZOPHRENIC-PATIENTS
Authors: VANBERCKEL BNM HIJMAN R VANDERLINDEN JA WESTENBERG HGM VANREE JM KAHN RS
Citation: Bnm. Vanberckel et al., TOLERANCE AND EFFICACY OF D-CYCLOSERINE IN DRUG-FREE SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 18(2-3), 1996, pp. 2-2
A DOUBLE-BLIND COMPARATIVE-STUDY OF BROFAROMINE AND FLUVOXAMINE IN OUTPATIENTS WITH PANIC DISORDER
Authors: VANVLIET IM DENBOER JA WESTENBERG HGM SLAAP BR
Citation: Im. Vanvliet et al., A DOUBLE-BLIND COMPARATIVE-STUDY OF BROFAROMINE AND FLUVOXAMINE IN OUTPATIENTS WITH PANIC DISORDER, Journal of clinical psychopharmacology, 16(4), 1996, pp. 299-306
DEVELOPMENTS IN THE DRUG-TREATMENT OF PANIC DISORDER - WHAT IS THE PLACE OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS
Authors: WESTENBERG HGM
Citation: Hgm. Westenberg, DEVELOPMENTS IN THE DRUG-TREATMENT OF PANIC DISORDER - WHAT IS THE PLACE OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS, Journal of affective disorders, 40(1-2), 1996, pp. 85-93
RESPONDERS AND NONRESPONDERS TO DRUG-TREATMENT IN SOCIAL PHOBIA - DIFFERENCES AT BASE-LINE AND PREDICTION OF RESPONSE
Authors: SLAAP BR VANVLIET IM WESTENBERG HGM DENBOER JA
Citation: Br. Slaap et al., RESPONDERS AND NONRESPONDERS TO DRUG-TREATMENT IN SOCIAL PHOBIA - DIFFERENCES AT BASE-LINE AND PREDICTION OF RESPONSE, Journal of affective disorders, 39(1), 1996, pp. 13-19
FLESINOXAN DOSE-DEPENDENTLY REDUCES EXTRACELLULAR 5-HYDROXYTRYPTAMINE(5-HT) IN RAT MEDIAN RAPHE AND DORSAL HIPPOCAMPUS THROUGH ACTIVATION OF 5-HT1A RECEPTORS
Authors: BOSKER FJ DEWINTER TYCE KLOMPMAKERS AA WESTENBERG HGM
Citation: Fj. Bosker et al., FLESINOXAN DOSE-DEPENDENTLY REDUCES EXTRACELLULAR 5-HYDROXYTRYPTAMINE(5-HT) IN RAT MEDIAN RAPHE AND DORSAL HIPPOCAMPUS THROUGH ACTIVATION OF 5-HT1A RECEPTORS, Journal of neurochemistry, 66(6), 1996, pp. 2546-2555
EFFECT OF THE CHOLECYSTOKININ-B RECEPTOR ANTAGONIST L-365,260 ON LACTATE-INDUCED PANIC ATTACKS IN PANIC DISORDER PATIENTS
Authors: VANMEGEN HJGM WESTENBERG HGM DENBOER JA
Citation: Hjgm. Vanmegen et al., EFFECT OF THE CHOLECYSTOKININ-B RECEPTOR ANTAGONIST L-365,260 ON LACTATE-INDUCED PANIC ATTACKS IN PANIC DISORDER PATIENTS, Biological psychiatry, 40(8), 1996, pp. 804-806
EFFICACY AND TOLERANCE OF D-CYCLOSERINE IN DRUG-FREE SCHIZOPHRENIC-PATIENTS
Authors: VANBERCKEL BNM HIJMAN R VANDERLINDEN JA WESTENBERG HGM VANREE JM KAHN RS
Citation: Bnm. Vanberckel et al., EFFICACY AND TOLERANCE OF D-CYCLOSERINE IN DRUG-FREE SCHIZOPHRENIC-PATIENTS, Biological psychiatry, 40(12), 1996, pp. 1298-1300
THE EFFECT OF THE CCK-B RECEPTOR ANTAGONIST CI-988 ON CCK-4 INDUCED PANIC ATTACKS
Authors: VANMEGEN HJGM WESTENBERG HGM DENBOER JA VANESRADHAKISHUN F
Citation: Hjgm. Vanmegen et al., THE EFFECT OF THE CCK-B RECEPTOR ANTAGONIST CI-988 ON CCK-4 INDUCED PANIC ATTACKS, Biological psychiatry, 39(7), 1996, pp. 431-431
DIFFERENTIAL-EFFECTS OF THE D1-DA RECEPTOR ANTAGONIST SCH139166 ON POSITIVE AND NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
Authors: DENBOER JA VANMEGEN HJGM FLEISCHHACKER WW LOUWERENS JW SLAAP BR WESTENBERG HGM BURROWS GD SRIVASTAVA ON
Citation: Ja. Denboer et al., DIFFERENTIAL-EFFECTS OF THE D1-DA RECEPTOR ANTAGONIST SCH139166 ON POSITIVE AND NEGATIVE SYMPTOMS OF SCHIZOPHRENIA, Psychopharmacology, 121(3), 1995, pp. 317-322
Risultati: 1-25 | 26-44